CAM
REGN icon

CG Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

CG Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.45M Buy
9,402
+1
+0% +$380 1.29% 23
2016
Q3 		$3.78M Sell
9,401
-45
-0.5% -$18.1K 1.41% 20
2016
Q2 		$3.3M Sell
9,446
-250
-3% -$96.3K 1.32% 22
2016
Q1 		$3.5M Sell
9,696
-2,043
-17% -$842K 1.4% 24
2015
Q4 		$6.37M Buy
11,739
+266
+2% +$144K 2.53% 8
2015
Q3 		$5.34M Buy
11,473
+18
+0.2% +$9.67K 2.26% 11
2015
Q2 		$5.84M Buy
11,455
+165
+1% +$80.5K 2.23% 11
2015
Q1 		$5.1M Buy
11,290
+1,865
+20% +$790K 1.98% 15
2014
Q4 		$3.87M Buy
9,425
+30
+0.3% +$11.8K 1.52% 25
2014
Q3 		$3.39M Buy
9,395
+1,115
+13% +$374K 1.39% 23
2014
Q2 		$2.34M Sell
8,280
-2,370
-22% -$702K 0.99% 36
2014
Q1 		$3.2M Buy
10,650
+80
+0.8% +$24.6K 1.44% 22
2013
Q4 		$2.91M Buy
+10,570
New +$3.04M 1.33% 30

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CG Asset Management's REGN Position: Q4 2016 in Review

CG Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.01% in Q4 2016, buying an estimated $380 and bringing the position to 9,402 shares worth $3.45M. The position accounts for 1.29% of the portfolio, ranked #23.

CG Asset Management first reported a position in REGN in Q4 2013 and has held it in 13 quarters since. The position peaked at $6.37M in Q4 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • CG Asset Management held 9,402 shares of Regeneron Pharmaceuticals worth $3.45M as of Q4 2016.
  • CG Asset Management bought 1 Regeneron Pharmaceuticals share in Q4 2016, an estimated $380.
  • Regeneron Pharmaceuticals made up 1.29% of CG Asset Management's portfolio in Q4 2016, its #23 holding.
  • CG Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 13 quarters since.
  • CG Asset Management's Regeneron Pharmaceuticals position peaked at $6.37M in Q4 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.